Ascertainment and verification of diabetes in the EPIC-NL study

Netherlands Journal of Medicine

Volumn 68, Issue 7-8, 2010, Pages 333-339

  Sluijs, I ^a   van der A, D L ^b   Beulens, J W J ^a   Spijkerman, A M W ^b   Ros, M M ^b   Grobbee, D E ^a   van der Schouw, Y T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Ascertainment; Diabetes; Hospital discharge diagnoses; Self report; Verification

Indexed keywords

ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; GLUCOSE TOLERANCE TEST; GROUPS BY AGE; HOSPITAL DISCHARGE; HUMAN; MALE; PHARMACY; PREVALENCE; QUESTIONNAIRE; SELF REPORT;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS; EUROPE; FEMALE; GENERAL PRACTITIONERS; GLYCOSURIA; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT DISCHARGE; QUESTIONNAIRES; YOUNG ADULT;

EID: 77957742643     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14(Suppl 5):S1-85.
2. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care. 1993;16:157-77.
3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-31.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
5. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7.
6. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci. 1999;21:217-20.
7. Ngo DL, Marshall LM, Howard RN, Woodward JA, Southwick K, Hedberg K. Agreement between self-reported information and medical claims data on diagnosed diabetes in Oregon's Medicaid population. J Public Health Manag Pract. 2003;9:542-4.
8. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57:1096-103.
9. Robinson JR, Young TK, Roos LL, Gelskey DE. Estimating the burden of disease. Comparing administrative data and self-reports. Med Care. 1997;35:932-47.
10. Simpson CF, Boyd CM, Carlson MC, Griswold ME, Guralnik JM, Fried LP. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc. 2004;52:123-7.
11. Skinner KM, Miller DR, Lincoln E, Lee A, Kazis LE. Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study. J Ambul Care Manage. 2005;28:102-10.
12. Tisnado DM, Adams JL, Liu H, et al. What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care. 2006;44:132-40.
13. Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol. 1999;149:541-9.
14. Riboli E, Hunt KJ, Slimani N et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113-24.
15. Beulens JW, Monninkhof EM, Verschuren MW, et al. Cohort Profile: The EPIC-NL study. Int J Epidemiol. 2010 [ahead of print].
16. Boker LK, van Noord PA, van der Schouw YT, et al. Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 2001;17:1047-53.
17. Blokstra A, Smit HA, Bueno-De-Mesquita HB, Seidell JC, Verschuren WMM. Monitoring van risicofactoren en gezondheid in Nederland (MORGEN-project), 1993-1997. Leefstijl- en risicofactoren: prevalenties en trends. RIVM rapport 26320008/2005 [in Dutch]. 2005.
18. Verschuren W, Blokstra A, Picavet H, Smit H. Cohort Profile: The Doetinchem Cohort Study. Int J Epidemiol. 2008.
19. Ocke MC, Bueno-De-Mesquita HB, Goddijn HE, et al. The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol. 1997;26(Suppl 1):S37-48.
20. Herings RM, Bakker A, Stricker BH, Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health. 1992;46:136-40.
21. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15:815-9.
22. Bergmann MM, Jacobs EJ, Hoffmann K, Boeing H. Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire. Eur J Epidemiol. 2004;19:411-6.
23. Paas RA, Veenhuizen CW. Onderzoek naar de betrouwbaarheid van de LMR. Rapportage voor de ziekenhuizen. Utrecht: Prismant [in Dutch]. 2002.
24. Andersson DK, Lundblad E, Svardsudd K. A model for early diagnosis of type 2 diabetes mellitus in primary health care. Diabet Med. 1993;10:167-73.
25. Bitzen PO, Schersten B. Assessment of laboratory methods for detection of unsuspected diabetes in primary health care. Scand J Prim Health Care. 1986;4:85-95.
26. Davidson JK, Reuben D, Sternberg JC, Ryan WT. Diabetes screening using a quantitative urine glucose method. Diabetes. 1978;27:810-6.
27. Friderichsen B, Maunsbach M. Glycosuric tests should not be employed in population screenings for NIDDM. J Public Health Med. 1997;19:55-60.
28. Hanson RL, Nelson RG, McCance DR, et al. Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med. 1993;153:2133-40.
29. West KM, Kalbfleisch JM. Sensitivity and specificity of five screening tests for diabetes in ten countries. Diabetes. 1971;20:289-96.